PPMD is proud to share some exciting news: our very own President and CEO, Pat Furlong, has been named the 2024 recipient of the prestigious Sonia Skarlatos Public Service Award by the American Society of Gene & Cell Therapy (ASGCT). The award was presented during ASGCT’s Annual Meeting in Baltimore, Maryland.

This esteemed award recognizes individuals who have demonstrated outstanding dedication to public service in the field of gene and cell therapy. Pat’s unwavering commitment to advancing research, impacting policy, improving care, and supporting families affected by Duchenne and Becker embodies the spirit of this award.

Throughout her tireless efforts, Pat has been a beacon of hope and inspiration for the Duchenne  community, leading initiatives that have propelled us closer to our mission of ending Duchenne. Her passion, leadership, and advocacy continue to make a significant impact on the lives of countless individuals living with Duchenne and Becker and their families.

Pat’s dedication to public service is a shining example for us all, motivating us to continue our collective efforts to accelerate progress and our commitment to fighting for every future. 

Join us in celebrating this momentous achievement and expressing gratitude for Pat’s extraordinary contributions to the Duchenne community. Congratulations, Pat, on this well-deserved honor!